from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1946c/lppG

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

0.986

Cap5-10ug/mL Capreomycintranslation

0.000

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.177

Rif0.2-5ug/mL Rifampicintranscription

0.000

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.675

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.788

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.110

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.753

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.355

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.893

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.145

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.521

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.839

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.577

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.272

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.594

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.130

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.317

KCN5-20 ug/mL Potassium cyaniderespiration

-0.213

NaN30.2-2 mM Sodium aziderespiration

-0.659

Nigericin50 uM Nigericinrespiration

0.253

TRC10-150 ug/mL Triclosanrespiration

-0.048

TRZ10-25 ug/mL Thioridazinerespiration

0.420

Valinomycin0.5-10 uM Valinomycinrespiration

-0.838

ZnSO42 mM ZnSO4respiration

0.088

menadione6-10 ug/mL Menadionerespiration

0.825

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.509

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

2.452

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.904

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.568

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

0.598

Cephalexin20-100 ug/mL CephalexincellWall

0.497

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.392

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.112

EMB10-20 ug/mL EthambutolcellWall

0.550

Eta12-40 ug/mL EthionamidecellWall

0.311

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.279

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.008

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.930

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.343

BZA0.12 mg/mL BenzamidearomaticAmides

0.167

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.331

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.068

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

-0.453

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.592

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.700

UVUV-irradiationDNAdamaging

0.091

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.730

Antimycin12.5-50 ug/mL Antimycin A?

-0.326

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.030

PA_110-50 ug/mL Antitubercular compound PA-1?

0.444

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.211

PA8240.2-2 ug/mL PA-824?

1.702

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.856

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.552

Verapamil50 uM Verapamil?

-0.259

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.176

methoxatin10-20 ug/mL Methoxatin?